Back
ProQR Therapeutics NV Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PRQR
ProQR Therapeutics NV
Last Price:
3.62
Seasonality Move:
18.99%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.ProQR Therapeutics NV Stock Forecast
-
Is ProQR Therapeutics NV Stock Undervalued?
The current ProQR Therapeutics NV [PRQR] share price is $3.61. The Score for PRQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal. - PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will ProQR Therapeutics NV Stock Go Up Next Year?
Data Unavailable
ProQR Therapeutics NV Stock Rating
Data Unavailable
ProQR Therapeutics NV Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
Netherlands
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
proqr.com
52-Week Data
52-Week High:
4.62
52-Week Low:
1.18
Prediction Charts
Market Cap:
382.32M
Price in USD:
3.61
Volume:
235.6K
Beta:
0.25
Technical Analysis
SMA50:
2.81
SMA100:
2.36
SMA200:
2.18
52-Wk Change:
154.23%
Stock Predictions
-
Is ProQR Therapeutics NV stock public?
Yes, ProQR Therapeutics NV is a publicly traded company. -
What is the ProQR Therapeutics NV stock quote today?
The ProQR Therapeutics NV stock price is 3.61 USD today. -
How to buy ProQR Therapeutics NV stock online?
You can buy ProQR Therapeutics NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-4 | 3.79 | 3.63 | 3.80 | 3.46 |
| Nov-5 | 3.70 | 3.58 | 3.75 | 3.49 |
| Nov-6 | 3.65 | 3.64 | 3.75 | 3.51 |
| Nov-7 | 3.60 | 3.57 | 3.73 | 3.50 |
| Nov-8 | 3.70 | 3.77 | 4.10 | 3.67 |
| Nov-11 | 3.87 | 3.95 | 4.07 | 3.80 |
| Nov-12 | 4.08 | 3.99 | 4.09 | 3.91 |
| Nov-13 | 3.99 | 3.98 | 4.21 | 3.92 |
| Nov-14 | 3.94 | 3.95 | 4.10 | 3.94 |
| Nov-15 | 3.96 | 3.82 | 4.00 | 3.69 |
| Nov-18 | 3.82 | 3.65 | 3.86 | 3.60 |
| Nov-19 | 3.65 | 3.60 | 3.75 | 3.58 |
| Nov-20 | 3.59 | 3.67 | 3.69 | 3.57 |
| Nov-21 | 3.67 | 3.61 | 3.70 | 3.59 |
ProQR Therapeutics NV Earnings
Data Unavailable
ProQR Therapeutics NV Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.06 per share.
* ProQR Therapeutics NV stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.